Metuchen Pharmaceuticals is a leading brand in the field of men's health. With a focus on addressing serious conditions such as erectile dysfunction and Peyronie's disease, they offer innovative solutions and therapies. Backed by a highly experienced leadership team, Metuchen is continuously researching and developing new formulations to expand their portfolio and improve the lives of men.

They have a proven track record in successful clinical development programs, regulatory approvals, and commercial launches. Metuchen Pharmaceuticals is known for their groundbreaking molecule in erectile dysfunction, which has been commercially available for some time. They are dedicated to increasing awareness, education, and therapeutic value in the field of men's sexual dysfunction.

In their ongoing efforts to serve underserved segments, Metuchen recently secured a global exclusive licensing agreement for a novel topical formulation for the treatment of Peyronie's disease. This potential treatment, currently undergoing early clinical testing, has the potential to be the first clinically proven topical and non-invasive solution for acute Peyronie's disease. With a commitment to addressing unmet needs in men's health, Metuchen Pharmaceuticals is at the forefront of innovation and aims to revolutionize the field with their diverse portfolio of therapies